Valuation: QuidelOrtho Corporation

Market Cap 1.18B 1.03B 949M 878M 1.67B 112B 1.69B 11.36B 4.45B 55.14B 4.42B 4.32B 191B P/E 2026 *
-10.8x
P/E 2027 * -108x
Enterprise Value 3.55B 3.1B 2.86B 2.65B 5.02B 338B 5.11B 34.25B 13.43B 166B 13.31B 13.02B 576B EV / Sales 2026 *
1.31x
EV / Sales 2027 * 1.24x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+1.74%
1 week-4.77%
Current month-0.77%
1 month+24.68%
3 months+22.83%
6 months-48.34%
Current year-39.15%
1 week 15.49
Extreme 15.49
18.77
1 month 11.84
Extreme 11.84
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
06-30Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
06-24Free

Director

22,743 0.0335%
06-24Free

Director

20,098 0.0296%
Change 5-day change 1-year change 3-year change Capi.($)
+1.74%-4.77%-44.95%-79.56% 1.18B
+5.90%+0.95%+6.97%-24.08% 15.79B
-0.17%-5.15%+29.00%+88.33% 1.62B
-0.26%-4.03%-30.05%+32.84% 1.09B
-1.25%-4.55%-30.84%-55.25% 614M
-0.99%-10.28%-41.69%-58.68% 537M
+1.91%+3.49%+30.25%-52.63% 453M
-0.80%+0.16%-56.32%-59.96% 377M
+2.12%-5.60%-26.58%-26.18% 323M
-2.47%-10.47%+30.52% - 287M
Average +0.55%-4.20%-13.37%-26.13% 2.23B
Weighted average by Cap. +4.23%-4.28%+1.02%-18.90%

Financials

2026 *2027 *
Net sales 2.71B 2.37B 2.19B 2.02B 3.84B 259B 3.9B 26.18B 10.26B 127B 10.17B 9.95B 440B 2.8B 2.45B 2.26B 2.09B 3.97B 267B 4.03B 27.04B 10.6B 131B 10.51B 10.28B 454B
Net income -156M -136M -126M -116M -221M -14.88B -224M -1.51B -590M -7.3B -585M -572M -25.3B -81.93M -71.68M -66.1M -61.16M -116M -7.82B -118M -792M -310M -3.84B -308M -301M -13.3B
Net Debt 2.37B 2.07B 1.91B 1.77B 3.36B 226B 3.41B 22.89B 8.97B 111B 8.89B 8.7B 385B 2.3B 2.01B 1.85B 1.72B 3.26B 219B 3.31B 22.21B 8.7B 108B 8.63B 8.44B 373B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-09 US$17.38 +0.75% 414,486
26-07-08 US$17.25 +1.47% 1,756,442
26-07-07 US$17.00 -5.56% 1,179,653
26-07-06 US$18.00 -1.37% 1,059,913
26-07-02 US$18.25 +0.39% 1,222,460
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
17.25USD
Average target price
20.50USD
Spread / Average Target
+18.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock